Intraperitoneal injection of purified recombinant Acrp30 lowers glucose levels in mice. To gain insight into the mechanism(s) of this hypoglycemic effect, purified recombinant Acrp30 was infused in conscious mice during a pancreatic euglycemic clamp. In the presence of physiological hyperinsulinemia, this treatment increased circulating Acrp30 levels by approximately twofold and stimulated glucose metabolism. The effect of Acrp30 on in vivo insulin action was completely accounted for by a 65% reduction in the rate of glucose production. Similarly, glucose flux through glucose-6-phosphatase (G6Pase) decreased with Acrp30, whereas the activity of the direct pathway of glucose-6-phosphate biosynthesis, an index of hepatic glucose phosphorylation, increased significantly. Acrp30 did not affect the rates of glucose uptake, glycolysis, or glycogen synthesis. These results indicate that an acute increase in circulating Acrp30 levels lowers hepatic glucose production without affecting peripheral glucose uptake. Hepatic expression of the gluconeogenic enzymes phosphoenolpyruvate carboxykinase and G6Pase mRNAs was reduced by more than 50% following Acrp30 infusion compared with vehicle infusion. Thus, a moderate rise in circulating levels of the adipose-derived protein Acrp30 inhibits both the expression of hepatic gluconeogenic enzymes and the rate of endogenous glucose production.
Terry P. Combs, Anders H. Berg, Silvana Obici, Philipp E. Scherer, Luciano Rossetti
Title and authors | Publication | Year |
---|---|---|
Lipopolysaccharide inhibition of glucose production through the Toll-like receptor-4, myeloid differentiation factor 88, and nuclear factor kappa b pathway
CF Raetzsch, NL Brooks, JM Alderman, KS Moore, PA Hosick, S Klebanov, S Akira, JE Bear, AS Baldwin, N Mackman, TP Combs |
Hepatology | 2009 |
Perspectives on Adipose Tissue, Chagas Disease and Implications for the Metabolic Syndrome
F Nagajyothi, MS Desruisseaux, LA Jelicks, FS Machado, S Chua, PE Scherer, HB Tanowitz |
Interdisciplinary Perspectives on Infectious Diseases | 2009 |
The Endocannabinoid System: Potential for Reducing Cardiometabolic Risk
HN Ginsberg, SC Woods |
Obesity | 2009 |
Adipocyte CREB promotes insulin resistance in obesity
L Qi, M Saberi, E Zmuda, Y Wang, J Altarejos, X Zhang, R Dentin, S Hedrick, G Bandyopadhyay, T Hai, J Olefsky, M Montminy |
Cell Metabolism | 2009 |
Obesity, airway hyperresponsiveness, and inflammation
SA Shore |
Journal of applied physiology | 2009 |
A novel pathway of insulin sensitivity in chromogranin A null mice: a crucial role for pancreastatin in glucose homeostasis
JR Gayen, M Saberi, S Schenk, N Biswas, SM Vaingankar, WW Cheung, SM Najjar, DT O'Connor, G Bandyopadhyay, SK Mahata |
The Journal of biological chemistry | 2009 |
Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial
JM Schenk, AR Kristal, ML Neuhouser, CM Tangen, E White, DW Lin, IM Thompson |
The Prostate | 2009 |
A rabbit model of pediatric nonalcoholic steatohepatitis: the role of adiponectin
JF Fu, YL Fang, L Liang, CL Wang, F Hong, GP Dong |
World journal of gastroenterology : WJG | 2009 |
Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin
GW Wong, SA Krawczyk, C Kitidis-Mitrokostas, G Ge, E Spooner, C Hug, R Gimeno, HF Lodish |
The FASEB Journal | 2009 |
MATERNAL SERUM ADIPONECTIN MULTIMERS IN PATIENTS WITH A SMALL-FOR-GESTATIONAL-AGE NEWBORN
S Mazaki-Tovi, R Romero, E Vaisbuch, O Erez, P Mittal, T Chaiworapongsa, SK Kim, P Pacora, L Yeo, F Gotsch, Z Dong, BH Yoon, SS Hassan, JP Kusanovic |
Journal of Perinatal Medicine | 2009 |
Maternal Serum Adiponectin Multimers In Gestational Diabetes
S Mazaki-Tovi, R Romero, E Vaisbuch, O Erez, P Mittal, T Chaiworapongsa, SK Kim, P Pacora, L Yeo, F Gotsch, Z Dong, BH Yoon, SS Hassan, JP Kusanovic |
Journal of Perinatal Medicine | 2009 |
Neuroendocrine inhibition of glucose production and resistance to cancer in dwarf mice
JM Alderman, K Flurkey, NL Brooks, SB Naik, JM Gutierrez, U Srinivas, KB Ziara, L Jing, G Boysen, R Bronson, S Klebanov, X Chen, JA Swenberg, M Stridsberg, CE Parker, DE Harrison, TP Combs |
Experimental Gerontology | 2009 |
Dysregulation of maternal serum adiponectin in preterm labor
S Mazaki-Tovi, R Romero, E Vaisbuch, O Erez, P Mittal, T Chaiworapongsa, SK Kim, P Pacora, L Yeo, F Gotsch, Z Dong, CL Nhan-Chang, C Jodicke, BH Yoon, SS Hassan, JP Kusanovic |
Journal of Maternal-Fetal and Neonatal Medicine | 2009 |
Proangiogenic Contribution of Adiponectin toward Mammary Tumor Growth In vivo
S Landskroner-Eiger, B Qian, ES Muise, AR Nawrocki, JP Berger, EJ Fine, W Koba, Y Deng, JW Pollard, PE Scherer |
Clinical cancer research | 2009 |
Chagas disease, adipose tissue and the metabolic syndrome.
Nagajyothi F, Desruisseaux MS, Weiss LM, Chua S, Albanese C, Machado FS, Esper L, Lisanti MP, Teixeira MM, Scherer PE, Tanowitz HB |
2009 |